|
Mar 14
|
Pfizer (NYSE:PFE) Faces Shareholder Proposals on Religious Discrimination and Executive Pay Limits
|
|
Mar 14
|
Biotech Alert: Searches spiking for these stocks today
|
|
Mar 14
|
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
|
|
Mar 14
|
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
|
|
Mar 13
|
Pfizer (PFE) Stock Moves -0.43%: What You Should Know
|
|
Mar 13
|
Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update
|
|
Mar 13
|
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
|
|
Mar 12
|
Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy According to Hedge Funds?
|
|
Mar 12
|
Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings
|
|
Mar 12
|
ARVN Stock Plunges 53% Following Mixed Data From Breast Cancer Study
|
|
Mar 11
|
Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug
|
|
Mar 11
|
Pfizer (NYSE:PFE) Announces Promising Phase 3 Results For Breast Cancer Therapy Vepdegestrant
|
|
Mar 11
|
Pfizer and Arvinas’s HER2-breast cancer drug extends PFS in certain patients
|
|
Mar 11
|
Arvinas gets positive breast cancer data, but finds differentiation a hard sell
|
|
Mar 11
|
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
|
|
Mar 11
|
Q4 2024 Biontech SE Earnings Call
|
|
Mar 10
|
Is Pfizer Inc. (PFE) the Most Undervalued US Stock to Buy According to Hedge Funds?
|
|
Mar 10
|
Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?
|
|
Mar 10
|
3 Reasons PFE is Risky and 1 Stock to Buy Instead
|
|
Mar 4
|
Q4 2024 Mersana Therapeutics Inc Earnings Call
|